Stockreport

Cassava Sciences plunges 40% after simufilam researcher indicted on fraud charges [Seeking Alpha]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF The charges against CUNY School of Medicine Professor Hoau-Yan Wang for falsifying data are regarding Cassava's Alzheimer's drug, simufilam, that Wang used to apply for [Read more]